Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit - USD ($) $ in Thousands	Total	Series A Redeemable Convertible Preferred Stock	Series B Redeemable Convertible Preferred Stock	Series C Redeemable Convertible Preferred Stock	Series D Redeemable Convertible Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning Balance at Dec. 31, 2019	$ (59,535)					$ 8	$ 3,951	$ (63,494)
Beginning Balance, Shares at Dec. 31, 2019		11,596,280	5,166,203	7,588,254
Beginning Balance at Dec. 31, 2019		$ 53,593	$ 36,336	$ 53,221
Beginning Balance at Dec. 31, 2019						7,778,552
Issuance of series D redeemable convertible preferred stock, net of issuance costs of $96	59				$ 89,904
Issuance of series D redeemable convertible preferred stock net of issuance costs of $96 share					6,902,872
Exercise of common stock options							(59)
SHARES, Exercised | shares						(65,881)
Vesting of restricted stock, Shares						547,360
Vesting of restricted stock	8						8
Stock-based compensation	3,091						3,091
Net loss	$ (39,341)							39,341
Ending Balance , Shares at Dec. 31, 2020	31,253,609	11,596,280	5,166,203	7,588,254	6,902,872
Ending Balance at Dec. 31, 2020	$ 233,054	$ 53,593	$ 36,336	$ 53,221	$ 89,904
Ending Balance, Shares at Dec. 31, 2020						8,391,793
Ending Balance at Dec. 31, 2020	(95,718)					$ 8	7,109	(102,835)
Exercise of common stock options	(181)						(181)
SHARES, Exercised | shares						(155,821)
Stock-based compensation	4,161						4,161
Conversion of redeemable convertible preferred stock into common stock upon initial public offering, Shares		11,596,280	(5,166,203)	7,588,254	6,902,872
Conversion of redeemable convertible preferred stock into common stock initial public offering		$ 53,593	$ 36,336	$ 53,221	$ 89,904
Conversion of redeemable convertible preferred stock into common stock upon initial public offering, shares						31,253,609
Conversion of redeemable convertible preferred stock into common stock upon initial public offering	233,053					$ 31	233,022
Initial public offering, net of underwriting discounts, commissions and net of offering costs of $11,786						7,500,000
Initial public offering, net of underwriting discounts, commissions and net of offering costs of $11,786	$ 115,714					$ 8	$ 115,706
Underwriters' exercise of overallotment option, net of underwriting discounts, commissions and initial public offering costs of $276, Shares						192,877
Underwriters' exercise of overallotment option, net of underwriting discounts, commissions and initial public offering costs of $276	3,003						3,003
Shares repurchased for cashless exercise	$ 10					$ 1,221	$ 10
Exercise of common stock warrants	19,303
Net loss	$ (58,160)							(58,160)
Ending Balance , Shares at Dec. 31, 2021		0	0	0	0
Ending Balance at Dec. 31, 2021		$ 0	$ 0	$ 0	$ 0
Ending Balance, Shares at Dec. 31, 2021						47,512,182
Ending Balance at Dec. 31, 2021	$ 202,224					$ 47	$ 363,172	$ (160,995)